News

Pharmaceutical stocks, including Pfizer (NYSE: PFE ... rebounded after Wall Street analysts highlighted the significant legal challenges the order would face. The pharmaceutical industry has ...
In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...
The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission ...
The DOJ launched an investigation into whether Chicago engaged in racially discriminatory hiring practices after Mayor ...
From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story ...
A top European court says the European Commission failed to provide a credible explanation for refusing The New York Times ...
EU Commission loses on all counts in Pfizergate legal case The EU’s top court annulled the Commission’s decision to deny the newspaper New York Times access to messages exchanged between President ...
Pfizer was founded in 1849 by two recent ... highlighting the increasing importance of legal and marketing issues over traditional R&D. He was succeeded by Ian Read and later Albert Bourla.
A top European court has ruled that the European Commission was wrong to refuse The New York Times access to text messages ...
The legal challenge carries a risk as well, as it could cupper the development of Enanta's drug – and possibly Pardes' – if Pfizer can prove it was the first to develop a drug candidate ...